Evidence map›Paper›PMID 38392049›Full record

Trial reportCurrent oncology (Toronto, Ont.)2024

Residents and Consultants Have Equal Outcomes When Performing Transrectal Fusion Biopsies: A Randomized Clinical Trial.

Beatrice Turchi, Riccardo Lombardo, Antonio Franco, Giorgia Tema, Antonio Nacchia, Antonio Cicione, Antonio Luigi Pastore, Antonio Carbone, Andrea Fuschi, Giorgio Franco and 2 more

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Biopsy strategies in the era of mpMRI: a comprehensive review.Prostate cancer and prostatic diseases · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Beatrice TurchiDepartment of Urology, Sapienza University of Rome, 00100 Rome, Italy.
Riccardo LombardoDepartment of Urology, Sapienza University of Rome, 00100 Rome, Italy.
Antonio FrancoDepartment of Urology, Sapienza University of Rome, 00100 Rome, Italy.
Giorgia TemaDepartment of Urology, Sapienza University of Rome, 00100 Rome, Italy.
Antonio NacchiaDepartment of Urology, Sapienza University of Rome, 00100 Rome, Italy.
Antonio CicioneDepartment of Urology, Sapienza University of Rome, 00100 Rome, Italy.ORCID 0000-0003-2889-5259
Antonio Luigi PastoreDepartment of Urology, Sapienza University of Rome, 00100 Rome, Italy.
Antonio CarboneDepartment of Urology, Sapienza University of Rome, 00100 Rome, Italy.ORCID 0000-0003-1725-1933
Andrea FuschiDepartment of Urology, Sapienza University of Rome, 00100 Rome, Italy.
Giorgio FrancoDepartment of Urology, Sapienza University of Rome, 00100 Rome, Italy.
Andrea TubaroDepartment of Urology, Sapienza University of Rome, 00100 Rome, Italy.
Cosimo De NunzioDepartment of Urology, Sapienza University of Rome, 00100 Rome, Italy.ORCID 0000-0002-2190-512X
Sapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of our study was to compare the performance of residents vs. consultants in transrectal fusion prostate biopsies (FUS-PBs), as well as patient-reported comfort. Between January 2021 and October 2022, a consecutive series of patients undergoing FUS-PBs were randomized into two groups: (A) FUS-PBs performed by a consultant; (B) FUS-PBs performed by trained residents (>50 procedures). All patients underwent FUS-PBs with 12 systematic cores and 3/6 target cores. The detection rate and number of positive cores in the target lesion were compared between groups, and the patient's discomfort after the procedure was evaluated using the VAS scale. Overall, 140 patients with a median age of 72 years were enrolled. Overall, 69/140 (49.3%) presented prostate cancer and 53/69 (76.8%) presented a clinically significant cancer (Grade Group ≥ 2). Consultants presented a detection rate of 37/70 (52.9%) and residents a detection rate of 32/70 (45.7%) (

Indexed as

ProstateProstatic NeoplasmsAgedConsultantsHumansImage-Guided BiopsyInternship and ResidencyMaleProspective Studiesconsultantsdetection rateprostate biopsyprostate cancerresidentstarget biopsy

Identifiers

PMID38392049
PMCPMC10887997
OpenAlexW4391383990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.